Indexes
Currency / Forex
Commodities
Market News
EUROPE MARKETS: European Stocks Reach For Fresh 2-year Highs As Spanish, Greek Shares Climb
Top / Flop
32,10+9.18%
188,13+4.73%
37,07+4.56%
54,67+3.13%
336,15-2.25%
238,14-2.45%
90,27-2.47%
66,14-3.30%
Headlines
Monday, 22 January
Icahn, Deason demand Xerox explore strategic options
1h ago - (Reuters) - Hedge fund managers Carl Icahn and Darwin Deason demanded on Monday that Xerox Corp (>> Xerox Corp) explore strategic alternatives and said they would join forces to elect four new members to the board, prodding the company's shares higher.
U.S. shutdown fears pressure dollar, mark worst run since 2015
44m ago - NEW YORK (Reuters) - The dollar held steady above a three-year low versus a basket of currencies on Friday, marking a fifth week of falls and its longest losing streak since May 2015 as worries over a possible U.S. government shutdown weighed.
Stocks shrug off U.S. government shutdown, dollar dips
2h ago - LONDON (Reuters) - World stocks and U.S. bond markets on Monday shrugged off a government shutdown in Washington, although the dollar pulled back and wallowed near three-year lows as the euro resumed its strong start to the year.
UBS lifts payouts for investors despite U.S. tax reform hit
2h ago - ZURICH (Reuters) - UBS (>> UBS Group) is increasing payouts to shareholders as growing business with its core base of wealthy clients helps to offset the effects of tighter regulation and a one-off 2.9 billion Swiss franc (2.17 billion pounds) hit from U.S. tax reforms.
Stocks flat but gamblers stumble on government clampdown worries
6h ago - MILAN (Reuters) - British shares steadied on Monday, supported by gains in the energy sector, though double-digit falls in gambling companies on fears of a government clampdown weighed on that sector.
Germany in Focus as Europe Ponders Banking Question
5h ago - By Patricia Kowsmann FRANKFURT -- Ten years ago, David Zimmer quit his management job to build his own fiber-optic network company in Germany....
Sanofi Nears Deal to Buy Hemophilia Drugmaker Bioverativ for More Than $11.5 Billion -- Update
14h ago - By Dana Mattioli and Jonathan D. Rockoff Sanofi SA is nearing a deal to buy hemophilia drugmaker Bioverativ Inc. for more than $11.5 billion...
Halliburton Revenue Rises, Bolstered by North American Market -- Earnings Review
3h ago - By Cara Lombardo Halliburton Co. shares rose 1.1% to $53.60 in premarket trading after the company reported its fourth-quarter earnings...
More news